- Home
- Articles
- latamerica
- diagnostics development
Refine by
Diagnostics Development Articles & Analysis
51 articles found
The mature ELANE enzyme is synthesized as a zymogen during neutrophil development and undergoes proteolytic activation and granule packaging within promyelocytes in the bone marrow. ...
These characteristics provide a strong guarantee for the rapid development and application of colored latex particles in medical diagnostic technology. ...
Rigorous quality assurance protocols accompany ADCs development services. Each development phase undergoes rigorous testing to ensure top safety standards and build confidence among medical professionals and patients. Alfa Cytology stresses the need to develop therapies that demonstrate both efficacy and safety reliability. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
Additionally, multiplex cytokine analysis is a valuable tool in vaccine development and drug discovery, providing real-time feedback on immune modulation. ...
Various preclinical models have been developed to mimic the multifaceted nature of NAFLD. These models can be broadly categorized into two main groups: cellular models and animal models. ...
By analyzing these interactions, scientists can identify new biomarkers for disease, develop targeted therapies, or discover novel glycan-binding proteins with potential applications in drug design. 2. ...
In the rapidly evolving world of biotechnology, synthetic peptides have emerged as a pivotal component with wide-ranging applications in medical research, diagnostics, and therapeutic developments. These lab-created sequences of amino acids mimic naturally occurring peptides and are instrumental in advancing scientific discoveries and pharmaceutical innovations. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to ...
Bioinformatics AnalysisBioinformatics tools and software can be used to predict potential glycosylation sites by identifying possible glycosylation sites by analyzing the features of protein or nucleic acid sequences.Glycosylation plays a key role in the development of many diseases. For example, in cancer, abnormal glycosylation patterns may lead to changes in protein function, ...
Cytoskeleton Technologies ·High-Resolution Microscopy The development of advanced microscopy techniques, such as super-resolution microscopy (e.g., STORM, PALM), has drastically improved our ability to visualize the cytoskeleton. ...
They have the advantages of small size, high stability, and good penetration, and therefore have a wide range of application prospects in the fields of clinical treatment, diagnostic reagent development, etc.Characteristics of NanobodiesThe size of nanobodies usually ranges between 10-15kDa, which is only 1/10 of the size of regular antibodies. ...
Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. Among the groundbreaking developments, cancer vaccines are a promising frontier1. These vaccines are transforming how we approach cancer treatment, leveraging the body's immune system to fight malignancies more effectively. ...
In cancer treatment, monoclonal antibodies (mAbs) can directly kill cancer cells, prevent the development of tumor blood vessels, and help the immune system kill cancer cells. ...
The enzyme is employed in the development of novel diagnostic tools and analytical methods, particularly in the detection and quantification of proline-containing compounds. ...
By profiling cytokine levels in cancer patients, researchers are able to identify patterns and correlations between cytokine levels and different stages of cancer development and progression. This information can then be used to develop new diagnostic and prognostic tools for cancer. ...
By profiling cytokine levels in cancer patients, researchers are able to identify patterns and correlations between cytokine levels and different stages of cancer development and progression. This information can then be used to develop new diagnostic and prognostic tools for cancer. ...
Identification of key lipids and related enzymes can help to identify potential abnormalities in metabolic pathways or pathogenic mechanisms, and eventually develop effective diagnostic and therapeutic tools. Depending on the focus of the study, lipidomics can be applied to the following pharmaceutical research. ...
However, thanks to advancements in medical research and technology, significant progress has been made in the field of rare disease research, from developing accurate diagnostic tools to making effective small-molecule drugs. ...
In the vast and intricate world of biology, the development of proteins and antibodies stands as a crucial field of study, driving advancements in medicine, biotechnology, and beyond. ...